Natera, Inc. Stock Analysis & AI Score
Natera, Inc. (NTRA) has an ST Score of 57.0 (B-), driven by its Growth (A+) and held back by its Profitability (D-). Analysts rate it Buy with a $372.73 price target (-8.2% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AINTRA Stock Price History
NTRA Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
NTRA Latest Stock News
ST Score
Natera, Inc. (NTRA) has an ST Score of 57.0 (B-), driven by its Growth (A+) and held back by its Profitability (D-). Analysts rate it Buy with a $372.73 price target (-8.2% downside).
- Strongest
- GrowthA+
- Weakest
- ProfitabilityD-
All factor grades
- GrowthA+
- SentimentA+
- Financial StrengthA-
- MomentumA-
- ValuationC
- ForecastD+
- ProfitabilityD-
- Piotroski3/9
Press Releases
Company Contact Details
NTRA stock: frequently asked questions
What is NTRA's ST Score?
Natera, Inc. (NTRA) has an ST Score of 57.0 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is NTRA a buy, hold, or sell?
Analysts rate NTRA a Buy, with a price target of $372.73 (-8.2% vs the current price). Our ST Score grades it B- (57.0/100). The ST Score is a data-driven signal, not a recommendation.
What are NTRA's factor grades?
Valuation C, Profitability D-, Financial Strength A-, Momentum A-, Growth A+, Forecast D+, Sentiment A+.
What is NTRA's valuation grade?
Natera, Inc. (NTRA) earns a valuation grade of C, measured against Medical - Diagnostics & Research peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is NTRA's growth grade?
Natera, Inc. (NTRA) earns a growth grade of A+, measured against Medical - Diagnostics & Research peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is NTRA's profitability grade?
Natera, Inc. (NTRA) earns a profitability grade of D-, measured against Medical - Diagnostics & Research peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is NTRA's financial strength grade?
Natera, Inc. (NTRA) earns a financial strength grade of A-, measured against Medical - Diagnostics & Research peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for NTRA?
The average analyst price target for Natera, Inc. (NTRA) is $372.73 from 28 analysts, which is -8.2% versus the recent price of $405.92.
What is NTRA's Piotroski score?
Natera, Inc. (NTRA) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.